Dr Eiluned Anne Hogenson, MD - Medicare Obstetrics/gynecology in Fairbanks, AK

Dr Eiluned Anne Hogenson, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Fairbanks, Alaska. She went to University Of Wisconsin School Of Medicine and graduated in 2000 and has 24 years of diverse experience with area of expertise as Obstetrics/gynecology. She is a member of the group practice Chena Obstetrics And Gynecology Pc and her current practice location is 1919 Lathrop St, Ste 222, Fairbanks, Alaska. You can reach out to her office (for appointments etc.) via phone at (907) 456-8197.

Dr Eiluned Anne Hogenson is licensed to practice in Alaska (license number 5178) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1558376954.

Contact Information

Dr Eiluned Anne Hogenson, MD
1919 Lathrop St, Ste 222,
Fairbanks, AK 99701-5942
(907) 456-8197
(907) 456-8192



Physician's Profile

Full NameDr Eiluned Anne Hogenson
GenderFemale
SpecialityObstetrics/gynecology
Experience24 Years
Location1919 Lathrop St, Fairbanks, Alaska
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Eiluned Anne Hogenson attended and graduated from University Of Wisconsin School Of Medicine in 2000
  NPI Data:
  • NPI Number: 1558376954
  • Provider Enumeration Date: 07/31/2006
  • Last Update Date: 04/25/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 5193783637
  • Enrollment ID: I20041229000938

Medical Identifiers

Medical identifiers for Dr Eiluned Anne Hogenson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1558376954NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology 5178 (Alaska)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Chena Obstetrics And Gynecology Pc519382780611

News Archive

Low levels of allopregnanolone hormone may predict risk of postpartum depression

In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.

State roundup: Arizona repeals CHIP program, Conn. insurance pool, Minnesota boosted by health bill

The Associated Press: "A controversial decision by Arizona lawmakers to eliminate a health insurance program for poor children puts it at risk of losing billions of dollars in federal Medicaid funding under the historic health care bill approved by Congress. Arizona last week became the first state to eliminate its Children's Health Insurance Program, removing an estimated 38,000 kids from the rolls starting in June in a budget-cutting move by Gov. Jan Brewer and the Republican-led Legislature. ... Rep. Kyrsten Sinema, D-Phoenix, told Brewer and House Speaker Kirk Adams in separate letters that eliminating the state's KidsCare program on June 15 would violate a 'maintenance of effort' requirement of the Senate health care overhaul bill approved by Congress" (Davenport, 3/22).

New cardiovascular home-monitoring program to detect concerning trends in postpartum women

America has the highest maternal mortality rate in the developed world, and it's getting worse. Since cardiovascular disease is the primary cause, researchers at the University of Pittsburgh School of Medicine and the Magee-Womens Research Institute created a blood pressure home-monitoring program to rapidly detect concerning trends in postpartum women before their situation becomes critical.

DSPA submits lurasidone NDA to the FDA

Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Eiluned Anne Hogenson allows following entities to bill medicare on her behalf.
Entity NamePeacehealth
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801965736
PECOS PAC ID: 9436067618
Enrollment ID: O20031106000460

News Archive

Low levels of allopregnanolone hormone may predict risk of postpartum depression

In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.

State roundup: Arizona repeals CHIP program, Conn. insurance pool, Minnesota boosted by health bill

The Associated Press: "A controversial decision by Arizona lawmakers to eliminate a health insurance program for poor children puts it at risk of losing billions of dollars in federal Medicaid funding under the historic health care bill approved by Congress. Arizona last week became the first state to eliminate its Children's Health Insurance Program, removing an estimated 38,000 kids from the rolls starting in June in a budget-cutting move by Gov. Jan Brewer and the Republican-led Legislature. ... Rep. Kyrsten Sinema, D-Phoenix, told Brewer and House Speaker Kirk Adams in separate letters that eliminating the state's KidsCare program on June 15 would violate a 'maintenance of effort' requirement of the Senate health care overhaul bill approved by Congress" (Davenport, 3/22).

New cardiovascular home-monitoring program to detect concerning trends in postpartum women

America has the highest maternal mortality rate in the developed world, and it's getting worse. Since cardiovascular disease is the primary cause, researchers at the University of Pittsburgh School of Medicine and the Magee-Womens Research Institute created a blood pressure home-monitoring program to rapidly detect concerning trends in postpartum women before their situation becomes critical.

DSPA submits lurasidone NDA to the FDA

Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.

Read more Medical News

› Verified 6 days ago

Entity NameChena Obstetrics & Gynecology Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639271323
PECOS PAC ID: 5193827806
Enrollment ID: O20070227000610

News Archive

Low levels of allopregnanolone hormone may predict risk of postpartum depression

In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.

State roundup: Arizona repeals CHIP program, Conn. insurance pool, Minnesota boosted by health bill

The Associated Press: "A controversial decision by Arizona lawmakers to eliminate a health insurance program for poor children puts it at risk of losing billions of dollars in federal Medicaid funding under the historic health care bill approved by Congress. Arizona last week became the first state to eliminate its Children's Health Insurance Program, removing an estimated 38,000 kids from the rolls starting in June in a budget-cutting move by Gov. Jan Brewer and the Republican-led Legislature. ... Rep. Kyrsten Sinema, D-Phoenix, told Brewer and House Speaker Kirk Adams in separate letters that eliminating the state's KidsCare program on June 15 would violate a 'maintenance of effort' requirement of the Senate health care overhaul bill approved by Congress" (Davenport, 3/22).

New cardiovascular home-monitoring program to detect concerning trends in postpartum women

America has the highest maternal mortality rate in the developed world, and it's getting worse. Since cardiovascular disease is the primary cause, researchers at the University of Pittsburgh School of Medicine and the Magee-Womens Research Institute created a blood pressure home-monitoring program to rapidly detect concerning trends in postpartum women before their situation becomes critical.

DSPA submits lurasidone NDA to the FDA

Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.

Read more Medical News

› Verified 6 days ago

Entity NamePeacehealth
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1396705539
PECOS PAC ID: 9436067618
Enrollment ID: O20080114000791

News Archive

Low levels of allopregnanolone hormone may predict risk of postpartum depression

In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.

State roundup: Arizona repeals CHIP program, Conn. insurance pool, Minnesota boosted by health bill

The Associated Press: "A controversial decision by Arizona lawmakers to eliminate a health insurance program for poor children puts it at risk of losing billions of dollars in federal Medicaid funding under the historic health care bill approved by Congress. Arizona last week became the first state to eliminate its Children's Health Insurance Program, removing an estimated 38,000 kids from the rolls starting in June in a budget-cutting move by Gov. Jan Brewer and the Republican-led Legislature. ... Rep. Kyrsten Sinema, D-Phoenix, told Brewer and House Speaker Kirk Adams in separate letters that eliminating the state's KidsCare program on June 15 would violate a 'maintenance of effort' requirement of the Senate health care overhaul bill approved by Congress" (Davenport, 3/22).

New cardiovascular home-monitoring program to detect concerning trends in postpartum women

America has the highest maternal mortality rate in the developed world, and it's getting worse. Since cardiovascular disease is the primary cause, researchers at the University of Pittsburgh School of Medicine and the Magee-Womens Research Institute created a blood pressure home-monitoring program to rapidly detect concerning trends in postpartum women before their situation becomes critical.

DSPA submits lurasidone NDA to the FDA

Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Eiluned Anne Hogenson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Eiluned Anne Hogenson, MD
1566 La Rue,
Fairbanks, AK 99709-6631

Ph: (907) 455-4063
Dr Eiluned Anne Hogenson, MD
1919 Lathrop St, Ste 222,
Fairbanks, AK 99701-5942

Ph: (907) 456-8197

News Archive

Low levels of allopregnanolone hormone may predict risk of postpartum depression

In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.

State roundup: Arizona repeals CHIP program, Conn. insurance pool, Minnesota boosted by health bill

The Associated Press: "A controversial decision by Arizona lawmakers to eliminate a health insurance program for poor children puts it at risk of losing billions of dollars in federal Medicaid funding under the historic health care bill approved by Congress. Arizona last week became the first state to eliminate its Children's Health Insurance Program, removing an estimated 38,000 kids from the rolls starting in June in a budget-cutting move by Gov. Jan Brewer and the Republican-led Legislature. ... Rep. Kyrsten Sinema, D-Phoenix, told Brewer and House Speaker Kirk Adams in separate letters that eliminating the state's KidsCare program on June 15 would violate a 'maintenance of effort' requirement of the Senate health care overhaul bill approved by Congress" (Davenport, 3/22).

New cardiovascular home-monitoring program to detect concerning trends in postpartum women

America has the highest maternal mortality rate in the developed world, and it's getting worse. Since cardiovascular disease is the primary cause, researchers at the University of Pittsburgh School of Medicine and the Magee-Womens Research Institute created a blood pressure home-monitoring program to rapidly detect concerning trends in postpartum women before their situation becomes critical.

DSPA submits lurasidone NDA to the FDA

Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.

Read more News

› Verified 6 days ago


Obstetrics & Gynecology Doctors in Fairbanks, AK

Dr. Sadie Marden, MD, MPH
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1717 W Cowles St, Fairbanks, AK 99701
Phone: 907-451-6682    
Dr. Dennis Weber, M.D.
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 1001 Noble St, Fairbanks, AK 99701
Phone: 907-459-3500    Fax: 907-459-3532
Dr. Doris Heilman, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1626 30th Ave., Fairbanks, AK 99701
Phone: 907-479-7701    Fax: 907-479-7718
Dr. Gina Pender, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1001 Noble St, Fairbanks, AK 99701
Phone: 907-459-3511    Fax: 907-459-3588
Kimberly Yu Schumacher, DO
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1919 Lathrop Street, Suite 222, Fairbanks, AK 99701
Phone: 907-456-8191    Fax: 907-456-8192
Ralph Alan Wells, MD
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 1860 Airport Way, 160b, Fairbanks, AK 99701
Phone: 907-455-7285    
Dr. Tess Harmon, MD
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 4076 Neely Rd, Fairbanks, AK 99709
Phone: 907-361-4000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.